Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
TALK - Talkspace Inc - Stock Price Chart
CompanyTalkspace Inc
IndustryHealth Information Services
Market Cap461.17MEPS (ttm)-0.12
P/E-EPS this Y105.56%
Forward P/E52.94EPS next Y681.96%
PEG-EPS past 5Y32.57%
P/S3.07EPS next 5Y-
P/B3.92EPS Q/Q93.21%
Dividend-Sales Q/Q40.27%
Insider Own31.20%Inst Own39.72%
Insider Trans0.00%Inst Trans-1.17%
Short Float2.57%EarningsFeb 22/b
Analyst Recom1.67Target Price4.00
Avg Volume981.74K52W Range0.58 - 2.85
WT - WisdomTree, Inc. - Stock Price Chart
TickerWT [NYSE, RUT]
CompanyWisdomTree, Inc.
IndustryAsset Management
Market Cap1.15BEPS (ttm)0.50
P/E15.16EPS this Y3.10%
Forward P/E13.97EPS next Y11.86%
PEG7.50EPS past 5Y6.80%
P/S3.38EPS next 5Y2.02%
P/B2.37EPS Q/Q-86.60%
Dividend1.57%Sales Q/Q24.90%
Insider Own0.80%Inst Own76.20%
Insider Trans33.80%Inst Trans-0.50%
Short Float7.85%EarningsFeb 02/b
Analyst Recom2.40Target Price8.50
Avg Volume1.26M52W Range5.53 - 7.55
WisdomTree, Inc., through its subsidiaries, operates as an exchange-traded funds (ETFs) sponsor and asset manager. It offers ETFs in equities, currency, fixed income, and alternatives asset classes. The company also licenses its indexes to third parties for proprietary products, as well as offers a platform to promote the use of WisdomTree ETFs in 401(k) plans. It develops index using its fundamentally weighted index methodology. In addition, the company provides investment advisory services. The company was founded in 1985 and is based in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Steinberg Jonathan LChief Executive OfficerFeb 13Buy7.20303,7812,186,7689,172,838Feb 14 09:18 AM
Steinberg Jonathan LChief Executive OfficerJan 29Option Exercise0.00260,61809,002,103Jan 31 04:47 PM
Peck William BradleyHead of Digital AssetsJan 29Option Exercise0.0015,8300202,388Jan 31 04:46 PM
Lilien R JarrettPresident and COOJan 29Option Exercise0.00143,38601,027,744Jan 31 04:44 PM
Marinof AlexisHead of EuropeJan 29Option Exercise0.0033,0720288,469Jan 31 04:45 PM
SAP - Sap SE ADR - Stock Price Chart
TickerSAP [NYSE]
CompanySap SE ADR
IndustrySoftware - Application
Market Cap215.48BEPS (ttm)2.94
P/E62.72EPS this Y-1.12%
Forward P/E26.54EPS next Y28.55%
PEG2.83EPS past 5Y6.98%
P/S6.39EPS next 5Y22.20%
P/B4.74EPS Q/Q128.15%
Dividend1.25%Sales Q/Q5.83%
Insider Own0.00%Inst Own5.63%
Insider Trans-Inst Trans2.92%
Short Float0.31%EarningsJan 24/b
Analyst Recom1.92Target Price194.89
Avg Volume770.06K52W Range112.57 - 181.93
COYA - Coya Therapeutics Inc - Stock Price Chart
CompanyCoya Therapeutics Inc
Market Cap91.04MEPS (ttm)-1.24
P/E-EPS this Y81.52%
Forward P/E-EPS next Y-6.02%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B9.02EPS Q/Q17.19%
Dividend-Sales Q/Q-
Insider Own14.09%Inst Own28.37%
Insider Trans0.00%Inst Trans-
Short Float0.16%EarningsNov 08/b
Analyst Recom1.00Target Price13.00
Avg Volume61.79K52W Range3.21 - 9.27
Feb-22-24 08:15AM Coya Therapeutics to Present Novel Biomarker Survival Data in Large Cohort of ALS (Amyotrophic Lateral Sclerosis) Patients at Society of Neuroimmune Pharmacology Conference (Business Wire)
Feb-21-24 08:15AM Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimers Disease and Coyas Pathway to a Pipeline in a Product (Business Wire) +7.94%
Feb-13-24 08:15AM Coya Therapeutics Licenses Intellectual Property Rights for Use of Next Generation Immune Modulatory Biologics in Combination with COYA 301 to Enhance Regulatory T Cells (Tregs) in Inflammatory Diseases (Business Wire)
Jan-29-24 08:15AM Coya Therapeutics SAB Chairman Dr. Stanley Appel, M.D. Selected as Speaker at the Society of Neuroimmune Pharmacology Conference (Business Wire)
Jan-18-24 08:15AM Coya Therapeutics to Participate in Upcoming Chardan Biotech Leadership Call Series (Business Wire)
Jan-16-24 08:15AM Coya Therapeutics Announces Pipeline Expansion of COYA 302 to Include Frontotemporal Dementia and Parkinsons Disease in Addition to Amyotrophic Lateral Sclerosis (Business Wire) -10.27%
03:59AM DISCO Pharmaceuticals launches as the surfaceome company with EUR 20 Million in Seed Financing (PR Newswire)
Jan-05-24 08:00AM Coya Therapeutics Announces Successful Pre-IND and Type C Meetings with the FDA to Advance the Development of COYA 302 for Treatment of Amyotrophic Lateral Sclerosis (ALS) (Business Wire)
Dec-20-23 08:30AM Mr. Wilbur L. Ross, Former United States Secretary of Commerce, Joins Board of Coya Therapeutics, Inc. (Business Wire) -7.66%
Dec-14-23 03:54PM David Einhorn's Greenlight Capital Boosts Coya Therapeutics Holding (
AER - Aercap Holdings N.V. - Stock Price Chart
TickerAER [NYSE]
CompanyAercap Holdings N.V.
IndustryRental & Leasing Services
Market Cap16.36BEPS (ttm)14.14
P/E5.51EPS this Y-6.83%
Forward P/E7.04EPS next Y10.69%
PEG1.02EPS past 5Y14.86%
P/S2.24EPS next 5Y5.40%
P/B0.95EPS Q/Q163.40%
Dividend-Sales Q/Q-2.15%
Insider Own0.00%Inst Own92.04%
Insider Trans-Inst Trans-0.81%
Short Float1.28%EarningsFeb 23/b
Analyst Recom1.20Target Price87.80
Avg Volume1.56M52W Range49.58 - 79.53
THC - Tenet Healthcare Corp. - Stock Price Chart
TickerTHC [NYSE]
CompanyTenet Healthcare Corp.
IndustryMedical Care Facilities
Market Cap9.28BEPS (ttm)5.83
P/E15.91EPS this Y-12.00%
Forward P/E12.88EPS next Y17.33%
PEG2.30EPS past 5Y40.40%
P/S0.45EPS next 5Y6.91%
P/B5.77EPS Q/Q144.28%
Dividend-Sales Q/Q7.80%
Insider Own3.01%Inst Own94.21%
Insider Trans-0.53%Inst Trans2.74%
Short Float3.90%EarningsFeb 08/b
Analyst Recom1.35Target Price107.40
Avg Volume1.06M52W Range49.76 - 92.90
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lynch Christopher S.DirectorFeb 15Sale89.607,978714,82925,620Feb 16 08:15 PM
FISHER RICHARD WDirectorFeb 14Sale88.212,100185,24120,127Feb 15 08:00 PM
FISHER RICHARD WDirectorNov 22Sale68.221,00068,22022,227Nov 24 04:17 PM
FISHER RICHARD WDirectorNov 21Sale66.335,000331,65023,227Nov 24 04:17 PM
Arbour Paola MEVP, Chief Information OfficerJun 02Option Exercise31.4638,5561,212,95254,357Jun 06 04:46 PM
HRB - H&R Block Inc. - Stock Price Chart
TickerHRB [NYSE]
CompanyH&R Block Inc.
IndustryPersonal Services
Market Cap6.85BEPS (ttm)3.63
P/E13.55EPS this Y10.99%
Forward P/E10.57EPS next Y9.55%
PEG1.35EPS past 5Y3.80%
P/S1.96EPS next 5Y10.00%
P/B-EPS Q/Q8.09%
Dividend2.64%Sales Q/Q7.62%
Insider Own1.23%Inst Own92.89%
Insider Trans-8.32%Inst Trans-1.26%
Short Float7.32%EarningsFeb 06/a
Analyst Recom2.50Target Price49.67
Avg Volume1.22M52W Range28.83 - 49.14
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jones Jeffrey J IIPresident & CEOFeb 23Sale49.2185,9214,228,593755,359Feb 23 05:30 PM
Jones Jeffrey J IIPresident & CEOFeb 15Sale48.0214,938717,353841,280Feb 20 04:31 PM
Bowen Tony GChief Financial OfficerNov 27Sale47.1046,8922,208,510125,591Nov 27 04:32 PM
Logerwell Kellie JVP & Chief Acct OfficerSep 11Sale39.618,000316,84527,721Sep 12 04:32 PM
Jones Jeffrey J IIPresident & CEOAug 16Sale38.0091,1923,465,296812,150Aug 16 08:31 PM
RL - Ralph Lauren Corp - Stock Price Chart
TickerRL [NYSE, S&P 500]
CompanyRalph Lauren Corp
IndustryApparel Manufacturing
Market Cap12.05BEPS (ttm)8.81
P/E21.38EPS this Y22.39%
Forward P/E16.83EPS next Y9.70%
PEG1.58EPS past 5Y30.87%
P/S1.82EPS next 5Y13.55%
P/B4.68EPS Q/Q30.86%
Dividend1.70%Sales Q/Q5.55%
Insider Own40.98%Inst Own63.24%
Insider Trans-0.39%Inst Trans-0.23%
Short Float9.57%EarningsFeb 08/b
Analyst Recom2.14Target Price189.94
Avg Volume882.45K52W Range103.17 - 187.87
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Alagoz HalideChief Product OfficerFeb 12Sale177.222,115374,82127,872Feb 14 04:01 PM
Alagoz HalideChief Product OfficerDec 14Sale143.012,000286,02029,987Dec 18 04:15 PM
Alagoz HalideChief Product OfficerNov 29Sale127.133,950502,16431,987Dec 01 04:03 PM
Louvet PatricePresident and CEONov 27Sale124.9395,75411,962,54791,972Nov 29 04:01 PM
Louvet PatricePresident and CEOJul 10Sale125.009,2721,159,000193,060Jul 12 05:07 PM
MRUS - Merus N.V - Stock Price Chart
CompanyMerus N.V
Market Cap2.74BEPS (ttm)-3.72
P/E-EPS this Y8.15%
Forward P/E-EPS next Y-17.25%
PEG-EPS past 5Y5.16%
P/S59.98EPS next 5Y-
P/B6.96EPS Q/Q20.07%
Dividend-Sales Q/Q67.65%
Insider Own25.36%Inst Own73.82%
Insider Trans-0.16%Inst Trans-1.87%
Short Float10.77%EarningsNov 02/a
Analyst Recom1.00Target Price45.36
Avg Volume542.45K52W Range17.15 - 47.36
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shuman HarryVP Controller, PAODec 19Sale26.681153,0687,002Dec 20 04:05 PM
Silverman Peter B.COO & GCDec 15Sale25.0022,386559,6500Dec 18 05:15 PM
Shuman HarryVP Controller, PAODec 08Sale24.442506,1107,117Dec 12 04:04 PM
Shuman HarryVP Controller, PAODec 01Option Exercise0.002,50007,942Dec 04 04:05 PM
Shuman HarryVP Controller, PAODec 01Sale24.5857514,1337,367Dec 04 04:05 PM
CSL - Carlisle Companies Inc. - Stock Price Chart
TickerCSL [NYSE]
CompanyCarlisle Companies Inc.
IndustryBuilding Products & Equipment
Market Cap17.01BEPS (ttm)13.55
P/E26.30EPS this Y18.85%
Forward P/E17.15EPS next Y12.60%
PEG1.75EPS past 5Y21.40%
P/S3.34EPS next 5Y15.00%
P/B6.01EPS Q/Q-24.84%
Dividend0.84%Sales Q/Q-22.54%
Insider Own0.90%Inst Own90.60%
Insider Trans-19.39%Inst Trans-0.78%
Short Float1.26%EarningsFeb 06/a
Analyst Recom2.14Target Price357.47
Avg Volume276.92K52W Range203.65 - 353.24
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KOCH D CHRISTIANChair, President & CEOFeb 22Option Exercise161.41719116,05487,371Feb 22 04:20 PM
KOCH D CHRISTIANChair, President & CEOFeb 22Sale350.00719251,65086,652Feb 22 04:20 PM
KOCH D CHRISTIANChair, President & CEOFeb 21Option Exercise161.4136,9475,963,615123,599Feb 22 04:20 PM
KOCH D CHRISTIANChair, President & CEOFeb 21Sale347.5436,94712,840,56086,652Feb 22 04:20 PM
KOCH D CHRISTIANChair, President & CEOFeb 16Option Exercise161.4116,8002,711,688103,452Feb 20 01:20 PM